Large Scale Biology Shares Up Despite 58-Percent Plunge in Q3 Revenue | GenomeWeb

This article has been updated to include share price.

NEW YORK, Nov. 4 (GenomeWeb News) - Shares in Large Scale Biology were up 3.16 percent at $.98 despite a 58-percent plunge in third-quarter revenue.


Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.